Practical Ways to Achieve Targets in Diabetes Care
S

Role of Lipoprotein (a) in Coronary Disease: An Emerging Novel Target

By Practical Ways to Achieve Targets in Diabetes Care FEATURING Steven Nissen
By Practical Ways to Achieve Targets in Diabetes Care FEATURING Steven Nissen
4,145 views
November 8, 2021
2 Comments
Login to view comments. Click here to Login

Featured Video

58:59
Philips

Live Case: Dr. George Adams Leverages Philips IVUS and Turbo-Power L…

Feat. G. Adams, F. Saab, J. Phillips, K. Madassery

Featured Video

12:08
Terumo Interventional Systems

Case Studies in Complex PCI: How to Achieve Success Through Radial A…

Feat. M. Patel

Related Content

AUTOPLAY
12:04
Stephen Kopecky

Role of PCSK9 Inhibitors in Diabetes

28:13
National Lipid Association

New Insights into Triglyceride Therapy and the Role of Omega-3 Fatty…

Feat. R. Mason
26:32
Practical Ways to Achieve Targets in Diabetes Care

Metabolic Surgery vs. Pharmacotherapy for Treatment of Obesity

Feat. S. Nissen
19:20
National Lipid Association

Colchicine: Now and What’s Next?

Feat. C. Ballantyne
21:10
National Lipid Association

Plant-based Diets for Improving Lipids

Feat. K. Williams
11:26
Houston Methodist DeBakey Heart and Vascular Center

Aspirin for the Primary Prevention of Cardiovascular Disease: What C…

Feat. M. Miedema
11:50
American Heart & Vascular Institute

New Medications for Heart Failure: SGLT2 Inhibitors and Vericiguat. …

Feat. M. Kittleson
40:00
San Diego Cardiovascular Interventions (SDCI) 2017

Incorporating Coronary Physiology in Decision Making

Feat. M. Kern
29:04
15th Annual Orange County Symposium for Cardiovascular Disease Prevention

LDL-C: Earlier and Lower Is Better and Safer?

Feat. P. Rosenblit
12:11
Complex Coronary Cases

Expanded Indications of Impella Protected PCI

Feat. J. Lasala
31:10
Insights from 2024 ACP Annual Meeting

ACP 2024 Insights: Acute Coronary Syndromes - Evaluation, Diagnosis …

Feat. D. Berg
30:00
Piedmont Heart Institute

Cardiometabolic Therapies: GLP-1 RAs and SGLT-2i

Feat. J. Burkle
25:54
13th Orange County Symposium for Cardiovascular Disease Prevention

SGLT2 inhibitors and GLP-1 agonists: Why Are They Important and Whic…

Feat. Y. Handelsman
11:23
Houston Methodist DeBakey Heart and Vascular Center

Perioperative Risk Assessment & Management: When Do I Need Cardi…

Feat. N. Faza
28:45
ASPC 2020 Virtual Summit on CVD Prevention

Apolipoprotein B & CVD Risk: How Can We Improve CVD Prevention W…

Feat. A. Sniderman
62:08
University of Louisville

Update on Coronary Revascularization

Feat. S. Ghafghazi
23:34
Northwell Fellows Course 2020

Mechanical Circulatory Support: From IABP to Heart Transplant

Feat. H. Fernandez
24:45
National Lipid Association

Cardiovascular Disease in Patients with HIV

Feat. W. R. Short
67:29
Philips

Step Ahead - PAD & CLI State of the Art and the COVID 19 Era Imp…

Feat. C. Walker, C. Lesar, S. Madassery, T. Yates
18:42
Cardiometabolic Health Congress (CMHC)

ASCVD Risk Assessment and Prevention: Where Do We Stand Now?

Feat. S. Virani